[Buruli ulcer involving the head: outcomes and therapeutic aspects in 8 cases observed at the University Hospital Center in Abidjan, Cote d'Ivoire].
Infection due to Mycobacterium ulcerans or Buruli ulcer usually occurs on the limbs (70%) or trunk (20%). Involvement of the head and neck region is less frequent but can lead to serious sequels. The purpose of this report is to describe 8 patients including 7 children who were treated for Buruli ulcers on the head in the dermatology department of the University Hospital Center in Abidjan, Cote d'Ivoire. Eye lesions and visual impairment were the most frequent sequels.
Kouame
K
K
Université de Cocody, Service de Dermatologie, CHU Treichville, Abidjan, République de Côte d'Ivoire.
Ecra
E
E
Cisse
M
M
Gbery
I
I
Kacou
E
E
Kassi
K
K
Kouassi
A
A
Ahogo
C
C
Yoboue
P
P
Kanga
J M
JM
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D054312:Buruli Ulcer / Q000473:pathology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D007560:Cote d'Ivoire; D017984:Enoxaparin / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000382:microbiology* / Q000628:therapy; D005145:Face; D005260:Female; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012720:Severity of Illness Index; D018461:Soft Tissue Infections / Q000382:microbiology* / Q000628:therapy; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D017984:Enoxaparin; D015242:Ofloxacin; D012293:Rifampin